MedTrace Logo

Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.

NCT04785209 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 640

Last updated 2024-05-31

No results posted yet for this study

Summary

Predicting no reflow in ppci of STEMI patients using mean platelet volume together with STEMI clinical risk scores

Conditions

  • No-Reflow Phenomenon

Interventions

OTHER

Mean platelet volume, lymphocyte number, STEMI clinical risk scores

Lab parameters

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Hamdy Shams elddin, Professor · Assiut University

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2021-02-28
Completion
2024-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04785209 on ClinicalTrials.gov